Sarcoma  >>  cabazitaxel  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
cabazitaxel / Generic mfg.
cabazL06470, NCT01913652 / 2012-003672-39: Ph II Cabazitaxel DD Liposarcoma

Completed
2
42
Europe
Cabazitaxel, Jevtana
European Organisation for Research and Treatment of Cancer - EORTC, Sanofi
Dedifferentiated Liposarcoma
12/20
12/20

Download Options